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ABSTRACT
Long-term sequelae of cancer and its treatment render
childhood cancer (CC) survivors vulnerable to cognitive and
behavioural difficulties and likely affect their quality of life
(QoL). Our aim was to compare levels of cognition,
psychosocial functioning, and health-related QoL of CC
survivors to healthy controls and examine the associations
between these three domains. Seventy-eight CC survivors
(age range = 7–16 years,≥ one year since cancer treatment)
and 56 healthy controls were included. Cognition (i.e., fluid
intelligence, executive functions, memory, processing
speed, and selective attention), psychosocial functioning,
and health-related QoL were assessed using standardized
tests and questionnaires. The cognitive performance,
parent-reported psychosocial behaviour, and health-related
QoL of the CC survivors were within the normative range.
However, working memory was significantly poorer in
survivors than controls, and visuospatial working memory
below the normative range was more commonly observed
among survivors than among controls. Processing speed
significantly predicted survivors’ performance in executive
functions. Among survivors, greater peer problems were
significantly associated with poorer cognitive functions and
health-related QoL. Despite the evidence for good
intellectual functioning, which might point towards
adequate reserves, in some survivors, domain-specific
difficulties may emerge years after cancer relating to
psychosocial development and QoL.
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Introduction
As childhood cancer (CC) survival rates have been increasing considerably over
the past few decades, special attention has been paid to adverse late effects.
Even though cancer treatment protocols are continuously modified to reduce
long-term sequelae (Mucci & Torno, 2015), cognitive late effects are often
reported (Krull et al., 2018; van der Linden et al., 2020). Cognitive problems
likely affect psychosocial behaviour and health-related quality of life (Ehrhardt
et al., 2018; Tonning Olsson et al., 2020). For instance, 29% to 59% of long-
term survivors who have been treated for leukemia (Krull et al., 2013) and
approximately 15% to 85% of adult survivors of childhood brain tumours
demonstrate cognitive impairment (Brinkman et al., 2016). These variations in
the reported figures are attributable to differential definitions of cancer sub-
groups, impairment, and the cognitive domain of interest. One cognitive
domain that is substantially affected is executive functions (Cheung et al.,
2016; Ehrhardt et al., 2018; Krull et al., 2018).
Executive functions are a set of late-maturing cognitive processes such as
working memory, inhibition, and cognitive flexibility (Miyake et al., 2000).
These complex cognitive subdomains facilitate learning and the achievement
of control over one’s behaviours. An important issue within the field of child
neuropsychology is young patients’ risk for cognitive deficits in later years.
Specifically, their cognitive performance might decline with age because
cancer and its treatment might hinder their achievement of developmental
milestones (Anderson et al., 2011). This phenomenon is most prominent
within late-maturing cognitive domains such as executive functions, because
developmental milestones relating to executive functions occur quickly after
one another (Ewing-Cobbs et al., 2004). Hence, executive functions merit
special attention in examinations of the severity of late effects.
Executive functions play a critical role in the development of psychosocial
behaviour (e.g., social competence, emotional distress), which is often
affected in CC survivors (Ehrhardt et al., 2018; Hocking et al., 2015; Moyer
et al., 2012), and this likely affects their quality of life (Vetsch et al., 2018). Never-
theless, research on quality of life following CC has yielded inconclusive results.
Indeed, some studies have found that survivors’ health-related quality of life
tends to be worse than that of their healthy peers, whereas others have
found that they report comparable or even better health-related quality of
life than their healthy counterparts (Vetsch et al., 2018). Ehrhardt et al. (2018)
and Tonning Olsson et al. (2020) have examined the relationship between cog-
nition, psychosocial functioning, and quality of life in adult survivors of CC and
demonstrated that cognitive impairment is associated with lower social attain-
ment (e.g., educational attainment, unemployment) and poorer health-related
quality of life. The findings of Puhr et al. (2019) highlight that in particular
lower executive functioning is associated with poorer social outcome (e.g.,
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educational adjustments, government support) in young adults after childhood
cancer.
Cancer type, treatment modality, age at diagnosis, and the time elapsed since
cancer treatment have been suggested to play key roles in the severity of cog-
nitive late effects (Brinkman et al., 2016; Krull et al., 2013; Krull et al., 2018). For
instance, CC survivors with central nervous system (CNS) involvement demon-
strate cognitive impairment more commonly than CC survivors without CNS
involvement (Ellenberg et al., 2009; Krull et al., 2018). Cancer treatment (e.g.,
CNS radiation therapy, chemotherapy) can adversely affect the myelinization
process (Saykin et al., 2003), and children with a younger age at diagnosis are
at greater risk for cognitive dysfunction because cerebral development is par-
ticularly vulnerable in early childhood (Anderson et al., 2011; Kahalley et al.,
2013; Krull et al., 2018). It has been proposed that complex interactions
between different risk factors determine recovery (Anderson et al., 2011).
Some survivors experience difficulties in one domain or across multiple
domains (e.g., cognition, psychosocial behaviour, quality of life), but others
do not present with adverse late effects (Brinkman et al., 2016; Conklin et al.,
2012; Kesler et al., 2010; Krull et al., 2013; Krull et al., 2018). The cognitive
reserve model postulates that, after recovering from an illness, an individual’s
functional outcome will vary because of differences in cerebral (e.g., brain con-
nectivity, cerebral perfusion) and cognitive reserve capacities (e.g., cognitive
performance before diagnosis), thereby leading to different cognitive and psy-
chosocial outcomes and altered quality of life (Richards & Deary, 2005; Stern,
2009). Thus, according to the cognitive reserve model, even when the cancer
type and treatment modalities of two survivors are the same, good age-appro-
priate functional outcomes may be observed in one survivor but not in the other
(Stern, 2009). The cognitive reserve model considers the effects of risk factors on
functional outcomes (e.g., location of the brain tumour, age at diagnosis)
(Dennis et al., 2014; Stern, 2009).
Up to now, there are only few studies investigating late effects of childhood
cancer including a multi-view perspective on cognition, psychosocial function-
ing, and quality of life (Ehrhardt et al., 2018). We therefore adopted a holistic
approach by not only investigating cognition, psychosocial functioning, and
health-related quality of life on their own, but also the relationship between
these functional domains. Similar to the conventions of standard clinical practice,
multiple domains were examined and different perspectives on functional out-
comes were adopted because such an approach can yield more comprehensive
insights into functional outcomes (Anderson et al., 2019; Lidzba et al., 2019). This
approach also permits the assessment of a possible hierarchical cascade; in other
words, more elementary cognitive functions (e.g., attention, processing speed)
can influence more complex ones such as executive functions (Rose et al., 2008).
Thus, our primary objectivewas to investigate functional outcomes among CC
survivors by assessing their cognitive performance (especially executive
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functions), parent-reportedpsychosocial behaviour, andhealth-related quality of
life and the relationship between these domains. We expected a majority of CC
survivors to demonstrate good functional outcomes. In contrast, we expected
a limited number of survivors, especially those with CNS involvement, to demon-
strate domain-specific difficulties relative to healthy controls. We expected that
cognition, psychosocial functioning, and health-related quality of life likely
affect one another. Since processing speed is claimed to be a major determinant
underlying deficits in executive functions (Mulder et al., 2011), we expected pro-
cessing speed to predict performance on tests of executive functions. Our second
objective was to examine the impact of clinical risk factors on cognition. In
accordance with the cognitive reserve model (Dennis et al., 2014; Richards &
Deary, 2005; Stern, 2009), we considered clinical risk factors (i.e., CNS involve-
ment, radiation therapy, age at diagnosis, years elapsed since cancer treatment)
to be indicators of threat to the functional outcomes of survivors. We hypoth-
esized that clinical risk factors will negatively impact on cognitive outcomes.
Method
In this study, we analyzed the data that were collected as a part of the Brainfit
Study, which was a multidisciplinary clinical trial that aimed to examine the cog-
nitive and neural characteristics of CC survivors and the efficacy of a cognitive
and a physical training (Benzing et al., 2018, 2020). All the data analyzed in
this study included solely pre-training assessments, hence none of the study
participants received any form of intervention at the time of assessment. This
study was conducted between January 2017 and December 2018 and was
approved by the local ethics committee (KEK) of Bern and Zurich, Switzerland
(KEK BE 196/15; KEK ZH 2015–0397; ICTRP NCT02749877).
Participants
CC survivors
A total of 262 survivors treated at the Children’s University Hospital in Bern and
Zurich and registered in the Swiss Childhood Cancer Registry were successfully
contacted by mail and phone. Twenty survivors did not meet the inclusion cri-
teria at the time of recruitment (e.g., relapse and readmission for cancer treat-
ment, older than the age criterion), and 161 eligible survivors declined the
invitation to participate in the study (e.g., the travel distance to the study
location was too far, participation required too much effort, current health
status, a lack of interest).
Thus, we recruited 81 7–16-year-old CC survivors. Inclusion criteria for survi-
vors were: (a) diagnosed with cancer within the past 10 years involving cancer
with CNS involvement (i.e., brain tumour, spinal cord) or without CNS involve-
ment (i.e., the brain and spinal cord were not directly affected by cancer) and
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(b) the termination of treatment (i.e., surgery, chemotherapy, and/or radiation
therapy) was at least 12 months prior to participation. With regard to survivors
without CNS involvement, only thosewhohad undergone chemotherapy or radi-
ation therapy in addition to surgery (i.e., tumour removal) were included. Survi-
vors with secondary, benign, and malignant tumours were included. The
exclusion criteria were as follows: (a) an unstable health status, (b) noncompli-
ance or substance abuse, and (c) an inability to follow study procedures. After
data collection, the data of three survivors were excluded from analyses
(relapse: n = 1, noncompliance: n = 1, language problems: n = 1). Thus, the final
sample size was 78 (without CNS involvement: n = 61, with CNS involvement:
n = 17). For the comparability of demographic and clinical variables between par-
ticipating andnon-participatingCC survivors, see the supplementary information
(S1 – S4). Participating and non-participating CC survivors did not significantly
differ in terms of sex, age at diagnosis, treatment duration, and years elapsed
since cancer treatment (see Tables S1–S3). Frequencies of cancer types and treat-
ment modalities were largely comparable between participating and non-parti-
cipating CC survivors (see Table S4). 19% of the participating CC survivors
received a combination of surgery, chemo- and radiotherapy. In contrast, only
7% of the non-participating CC survivors received a combination of surgery,
chemo- and radiotherapy. Conversely, surgery only (11% versus 18%) and
surgery in combination with chemotherapy (24% versus 34%) was slightly less
represented by participating CC survivors than by non-participating survivors.
Healthy controls
We recruited 57 7–16-year-old children and adolescents who were comparable
to the group of CC survivors in terms of age and sex. They all had normal or cor-
rected-to-normal hearing and vision. The exclusion criteria were as follows: (a) a
chronic illness that can potentially influence development (e.g., birth deformity,
congenital heart defect, cerebral palsy, epilepsy), (b) medical problems that can
potentially influence development (e.g., encephalopathy, traumatic brain
injury), (c) developmental disorders (e.g., autism, attention deficit/hyperactivity
disorder), (d) mental disorders, (e) noncompliance or substance abuse, and (f) an
inability to follow study procedures. These controls were the siblings of the sur-
vivors (n = 2) or were recruited through recruitment advertisements, which were
posted on the hospital website and circulated within the neighbourhood. One
participant was excluded because he had a history of anorexia nervosa, which
was unknown to the examiners at the time of assessment. The data of the
remaining 56 controls were analyzed.
Procedure
Before administering the assessments, we sent an information letter and a study
information booklet to eligible participants and conducted a standardized
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screening interview over the telephone to ensure that the inclusion criteria were
met. All the participants and the legal guardians of participants who were
younger than 14 years of age provided written informed consent before they
responded to the assessments in accordance with the Code of Ethics of the
World Medical Association (i.e., Declaration of Helsinki).
The participants underwent a neuropsychological assessment that lasted for
1.5 h (including a break) at the Children’s Hospital in Bern or Zurich. The neurop-
sychological tests were administered by trained psychologists. The participants
and their caregivers also completed a set of standardized questionnaires. The
participants received 30 Swiss francs and a gift voucher, and their travel costs
were reimbursed.
Measures
Socioeconomic status (SES) was assessed using the German version of the
Family Affluence Scale II (Boudreau & Poulin, 2008). The composite score can
range from one to nine, and higher scores are indicative of a higher SES.
Cognitive performance tasks
Fluid intelligence was measured using the Test of Nonverbal Intelligence (Brown
et al., 2010). In accordance with the model that has been developed by Miyake
et al. (2000), we assessed the following executive functions: verbal working
memory using the number recall and word order subtests of the German
Version of the Kaufman Assessment Battery for Children (K-ABC II; Melchers &
Preuss, 2003), visuospatial working memory using the block recall subtest of
the Working Memory Test Battery for Children (Pickering & Gathercole, 2001),
inhibition, and cognitive flexibility using the color-word interference test of
the Delis-Kaplan Executive Function System (Delis et al., 2001). The completion
time and number of errors committed on the inhibition and cognitive flexibility
tasks were recorded. Furthermore, planning (assessed using the Rover subtest),
verbal memory (assessed using the Atlantis and Atlantis recall subtests of the K-
ABC II), selective attention (assessed using the cancellation subtest), and proces-
sing speed (assessed using the coding and symbol search subtests of the
German version of the Wechsler Intelligence Scale for Children, fourth edition
(Wechsler, 2003)) were assessed. The raw scores were transformed into standard
(M = 100, SD = 15) or scaled scores (M = 10, SD = 3) based on norms presented in
the respective test manuals.
Measures of psychosocial functioning and quality of life
Psychosocial behaviour was assessed using the German parent-report version of
the Strengths and Difficulties Questionnaire (Goodman, 1997). It yields a total
difficulties score (subscales: emotional problems, conduct problems, hyperactiv-
ity/inattention, peer problems) and includes a prosocial behaviour scale. Total
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scores can range from one to seven; four represents an average score, and
higher scores are indicative of greater difficulties. Health-related quality of life
was assessed using the German parent- and self-report versions of the Kidsc-
reen-10 Index (Ravens-Sieberer et al., 2014). Raw scores were transformed
into T-scores using existing norms for the Swiss population. Higher T-scores
are indicative of better health-related quality of life.
Missing value imputation
Using the predictive mean matching algorithm (five datasets), missing values
that were attributable to the following reasons were imputed based on all
the variables that were embedded within the dataset (Sterne et al., 2009): (a)
unavailable age norms, (b) unreturned questionnaires, or (c) non-evaluable
tests (e.g., because of difficulties in administration). Consequently, 7.8% of the
data points, classifiable as missing at random, were imputed. The pattern of
results remained the same, irrespective of whether the analyses were conducted
with or without imputed data. Thus, for all the analyses, the imputed data of 78
CC survivors and 56 controls were included.
Statistical analyses
All analyses were conducted using IBM SPSS (version 25.0). Based on the Maha-
lanobis distance (Fidell & Tabachnick, 2003), we ascertained that none of the
participants were probable multivariate outliers. For all the analyses, the signifi-
cance level was set at p < .05. Hedges’ g was computed to estimate effect size.
To address our primary objective, the first set of analyses was conducted to
compare CC survivors and controls, and the second set of analyses was con-
ducted to compare CC survivors with and without CNS involvement (subgroup
analyses). Because the group sizes were unequal, we did not conduct an
ANOVA. Comparing survivors against healthy peers guaranteed a comparison
control group uniformly tested across all outcome variables. Further, Pearson’s
chi-square test was used to examine group differences in sex distribution and
frequencies of cognitive performance below the normative range (i.e., scaled
score < 7; standard score < 85). To identify survivors at risk to show any altera-
tions in developmental pathways, i.e., cognitive difficulties, the cut-off value
of 1 SD below the normative mean was chosen (see Beauchamp et al. (2015)).
Group differences in the following continuous variables were examined using
independent-samples t-test: demographic variables (i.e., age and SES), clinical
risk factors (i.e., age at diagnosis, treatment duration, and years since cancer
treatment), and the scores yielded by the cognitive performance tests and stan-
dardized questionnaires. Two-tailed tests were conducted to examine group
differences in demographic and clinical variables and health-related quality of
life. Based on a review of the extensive literature on the sequelae of CC
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(Hocking et al., 2015; Krull et al., 2018), one-tailed tests were conducted to
examine the cognitive and psychosocial variables. Two-tailed Pearson’s corre-
lation analysis was conducted to examine the relationship between cognitive
performance and the scores that were yielded by the questionnaires among sur-
vivors and among controls. Additionally, forced-entry hierarchical multiple
regression analyses were conducted to examine the effects of processing
speed and CNS involvement on the executive functions of survivors. CNS invol-
vement was entered into the model in the first step, and processing speed was
entered in the second step.
To address our second objective, forced-entry hierarchical multiple
regression analyses were conducted. In the first step, CNS involvement
was entered into the model. In the second step, the clinical risk factors
(i.e., radiation treatment, age at diagnosis, and years elapsed since cancer
treatment) were entered as additional predictors. The cognitive domains
in which the two groups of survivors significantly differed, served as the
outcome variables.
Results
Differences between childhood cancer survivors and controls
The two groups were comparable in terms of age, sex, and SES (Table 1). The
clinical characteristics of the CC survivors are presented in the supplementary
information (Table S4).
The mean performance scores of the CC survivors and controls were within
the normative range across all the cognitive domains (Table 2). There were sig-
nificant group differences in executive functions (i.e., verbal and visuospatial
working memory, inhibition, and cognitive flexibility), verbal memory, selective
attention, and processing speed; specifically, the survivors performed worse
than the controls. Visuospatial working memory below the normative range
occurred in 19% of the CC survivors and was more commonly observed
among CC survivors than among the controls (x2 = 5.4, p = .022, d = 0.41). The
groups did not differ significantly in any of the other cognitive domains (see
Figure 1).
The mean parent-reported psychosocial behaviour and health-related quality
of life scores of the survivors and controls were within the normative range
(Table 3). However, the survivors obtained significantly higher total difficulties
scores than the controls. Specifically, there were significant group differences
in conduct problems, peer problems, and hyperactivity/inattention. The two
groups did not differ significantly in their health-related quality of life.
The severity of conduct, r(78) =−0.252, p = .029, and peer problems, r(78) =
−0.423, p < .0005, were negatively correlated with visuospatial working
memory performance among survivors. In survivors, the severity of peer
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Table 1. Demographic and clinical data.
Controls (n = 56) CC survivors (n = 78) CC subgroups (n = 78)
without CNS involvement
(n = 61)
with CNS involvement
(n = 17)
Mean (SD)
range
Mean (SD)
range t/ p
Mean (SD)
range
Mean (SD)
range t/ p
Age 11.49 (2.75)
7.0 – 16.2
11.23 (2.49)
7.3 – 16.7
0.58 .565 10.90 (2.32)
7.28 – 15.56
12.42 (2.80)
7.98 – 16.70
−2.29 .025*
Sex (female/male) 27/29 32/46 0.68 .408 25/36 7/10 < 0.01 .989
SES 6.84 (1.49)
4 – 9
6.6 (1.43)
2 – 9
0.77 .446 6.58 (1.60)
2 – 9
6.68 (1.77)
2 – 9
−0.2 .843
Age at diagnosis N/A 5.38 (3.13)
0.6 – 12.7
N/A N/A 4.94 (3.04)
0.67 – 12.74
6.95 (3.05)
0.57 – 12.13
2.4 .019*
Treatment duration N/A 1.34 (0.92)
0.0 – 3.6
N/A N/A 1.45 (0.84)
0.15 – 3.18
0.93 (1.09)
0.00 – 3.63
−2.13 .036*
Years since cancer treatment N/A 4.51 (2.04)
1.1 – 9.2
N/A N/A 4.50 (2.05)
1.13 – 9.15
4.55 (2.08)
1.11 – 7.48
0.08 .939
Note. Units of age, age at diagnosis, and treatment duration = years; N/A = not applicable; SD = standard deviation;
n = sample size; CC = childhood cancer; SES = socio-economic status: ranging from 1 to 9, with higher scores representing higher SES; t = t-value;
= chi-square; p = level of statistical significance, * < .05.
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problems was further negatively correlated with inhibition (completion time: r
(78) =−0.259, p = .028), cognitive flexibility (completion time: r(78) =−0.436, p
< .0005; errors: r(78) =−0.294, p = .009), processing speed (r(78) =−0.351, p
Table 2. Cognitive functions.
Controls
(n = 56)
CC survivors
(n = 78)
Mean (SD)
range
Mean (SD)
range t p Effect sizec
Fluid intelligencea 107.36 (12.22) 105.99 (11.69) 0.66 .291 0.10
85 – 132 82 – 136
Working memory verbala 101.8 (13.09) 96.47 (11.63) 2.48 .007* 0.44
78 –146 73 – 128
visuospatiala 108.28 (16.84) 100.48 (18.85) 2.45 .007* 0.43
73 – 140 56 – 145
Inhibition completion timeb 11.07 (2.44) 9.92 (2.86) 2.42 .008* 0.43
4 –15 1 – 15
errorsb 11.00 (2.19) 10.96 (2.21) 0.10 .460 0.02
3 – 14 3 – 14
Cognitive flexibility completion timeb 10.95 (2.61) 9.98 (2.83) 1.96 .025* 0.35
2 – 16 1 – 14
errorsb 10.83 (2.38) 10.56 (2.30) 0.65 .259 0.12
4 – 15 4 – 14
Planningb 12.57 (2.43) 11.99 (2.70) 1.29 .101 0.22
5 – 17 5 – 18
Verbal memoryb 12.55 (2.34) 11.72 (2.59) 1.92 .028* 0.33
8.5 – 17.5 5.0 – 17.5
Selective attentionb 10.81 (2.79) 9.67 (3.42) 2.04 .021* 0.36
5 – 16 1 – 18
Processing speeda 105.5 (12.37) 101.42 (16.10) 1.66 .007* 0.28
79 – 134 53 – 131
Note. CC = childhood cancer; N/A = not applicable; SD = standard deviation; n = sample size; t = t-value,
p = level of statistical significance, * < .05.
aStandard score (mean 100, SD 15)
bScaled score (mean 10, SD 3)
cg Hedges for continuous variables with unequal sample sizes
Figure 1. Percentage of childhood cancer (CC) survivors and controls with performance below
the normative range in cognitive domains. The dotted line indicates the cut-off of the percen-
tage of survivors expected to perform below the normative range according to the Gaussian
distribution.
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Table 3. Psychosocial functions and health-related quality of life.
Controls
(n = 56)
CC survivors
(n = 78)
CC subgroups
without CNS
involvement
(n = 61)
with CNS
involvement
(n = 17)
Mean (SD) Mean (SD) t p
Effect
sizec Mean (SD) Mean (SD) t p
Effect
sizec
Psychosocial behaviora
Total difficulty score 4.06 (0.30) 4.34 (0.71) −2.62 .005* 0.49 4.26 (0.76) 4.61 (0.91) −1.43 .078 0.44
Emotional problems 4.21 (0.49) 4.31 (0.63) −0.93 .178 0.17 4.26 (0.73) 4.48 (0.77) −1.05 .149 0.30
Conduct problems 4.20 (0.50) 4.40 (0.71) −1.75 .041* 0.32 4.37 (0.85) 4.48 (0.75) −0.54 .300 0.13
Hyperactivity/Inattention 4.10 (0.33) 4.31 (0.55) −1.88 .034* 0.45 4.24 (0.61) 4.54 (0.83) −1.32 .093 0.45
Peer problems 4.20 (0.49) 4.50 (0.79) −2.61 .005* 0.44 4.34 (0.66) 5.05 (1.20) −2.73 .003* 0.88
Prosocial behavior 4.18 (0.51) 4.16 (0.48) 0.13 .449 0.04 4.12 (0.42) 4.33 (0.62) −1.22 .113 0.45
Health-related quality of lifeb
Parent-reports 53.10 (9.95) 50.89 (10.84) 1.15 .246 0.21 51.80 (9.58) 47.61 (13.59) 1.3 .198 0.39
Self-reports 51.42 (12.35) 51.05 (12.48) 0.17 .87 0.03 52.41 (12.17) 46.18 (12.50) 1.57 .124 0.51
Note. CC = childhood cancer; SD = standard deviation; n = sample size; t= t-test; p = level of statistical significance, *< .05.
arange of entire scale: 1–7; 4 = average, > 5 = slightly raised, ≥ 6 raised
bT-values (mean 50, SD 10): higher values indicate higher quality of life
cg Hedges for variables with unequal sample sizes
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= .002), selective attention (r(78) =−0.327, p = .006), fluid intelligence (r(78) =
−0.226, p = .048), and parent reported health-related quality of life (r(78) =
−0.425, p < .0005). This indicates that the survivors who reported greater psy-
chosocial problems performed poorer on tasks measuring executive functions,
processing speed, selective attention, and fluid intelligence, and reported lower
quality of life. For the control group, none of these associations were significant
(for details on all correlational analyses and Bonferroni-corrected results, see
Table S5 in the supplementary information).
Differences between the two survivor subgroups
Survivors with and without CNS involvement were comparable in terms of sex,
SES, and years since cancer treatment. However, survivors with CNS involve-
ment were significantly older at the time of assessment and diagnosis and
had received treatments for shorter durations of time than their counterparts
without CNS involvement (Table 1).
There were significant subgroup differences in cognitive flexibility, verbal
memory, selective attention, and processing speed; specifically, survivors with
CNS involvement performed worse on the tests that measured these variables
(see Table 4). Performance below the normative range in cognitive flexibility
(completion time: x2 = 9.82, p = .002, d = 0.76; errors: x2 = 11.12, p = .001, d =
0.82), selective attention (x2 = 5.35, p = .021, d = 0.54), and processing speed
(x2 = 4.21, p = .040, d = 0.48) were more commonly observed among survivors
with CNS involvement. More specifically, depending on the cognitive domain,
a maximum of 35% and 16% of survivors with and without CNS involvement
demonstrated cognitive performance below the normative range, respectively
(Figure 2). The parents of survivors with CNS involvement reported greater
severity of peer problems than the parents of those without CNS involvement.
The two subgroups did not differ in their health-related quality of life (Table 3).
Impact of processing speed on the executive functions of survivors
The predictor CNS involvement explained 26.7% of the variance in cognitive
flexibility (completion time: F(1,76) = 24.3; p < .0005, β = – 3.35; p < .0005). Pro-
cessing speed significantly predicted performance on tests of all the subdo-
mains of executive functions (verbal working memory: β = 0.291, p < .0005;
visuospatial working memory: β = 0.407, p = .002; inhibition [completion
time]: β = 0.111, p < .0005; cognitive flexibility [completion time]: β = 0.083,
p < .0005). Processing speed and CNS involvement together accounted for
12.6% of the variance in verbal working memory (F(2,75) = 6.57, p = .002),
11.8% of the variance in visuospatial working memory (F(2,75) = 6.16, p
= .003), 37.2% of the variance in inhibition (completion time: F(2,75) = 23.45,
p < .0005), and 43.1% of the variance in cognitive flexibility (completion
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time: F(2,75) = 30.21, p < .0005). Consequently, processing speed explained an
additional 16.4% of the variance in the average time taken to complete the
cognitive flexibility task. With regard to accuracy (i.e., the number of errors
committed on the inhibition and cognitive flexibility tasks), processing
speed failed to emerge as a significant predictor. However, processing
speed and CNS involvement explained 5.7% of the variance in inhibition
errors (F(2,75) = 3.26, p = .043) and 11.8% of the variance in cognitive flexi-
bility errors (F(2,75) = 5.89, p = .004). For details, see supplementary infor-
mation (Table S6).
Impact of risk factors
Cerebral development is considered to be particularly vulnerable during the
first three years of life (Anderson et al., 2010; Gilmore et al., 2018). Therefore,
the following groups, which differed in their age at diagnosis, were com-
pared: < 3 years old at diagnosis (n = 23; M ± SD = 2.0 ± 0.1) and≥ 3 years
old at diagnosis (n = 55; M ± SD = 6.8 ± 0.4). Younger age at diagnosis signifi-
cantly predicted poorer verbal memory (β = 2.08, p = .001) but none of the
Table 4. Cognitive functions of childhood cancer subgroups.
CC survivors
without CNS
involvement
(n = 61)
with CNS
involvement
(n = 17)
Mean (SD)
range
Mean (SD)
range t/ F p
Effect
sizec
Fluid
intelligencea
106.82 (11.98) 103.00 (10.37) 1.2 .118 0.33
82 – 136 83 – 121
Working
memory
verbala 96.69 (11.80) 95.71 (11.31) 0.31 .380 0.08
75 – 128 73 – 111
visuospatiala 102.23 (17.94) 94.22 (21.19) 1.56 .059 0.43
56 – 145 56 – 131
Inhibition completion
timeb
10.20 (2.74) 8.92 (3.13) 1.61 .054 0.45
1 – 15 1 – 15
errorsb 11.16 (2.07) 10.21 (2.61) 1.57 .058 0.43
6 – 14 3 – 14
Cognitive
flexibility
completion
timeb
10.71 (2.07) 7.36 (3.61) 3.62 < .0005*
.001***
1.35
5 – 14 1 – 13
errorsb 10.92 (1.83) 9.28 (3.25) 1.95 .026* 0.74
6 – 14 4 – 15
Planningb 12.20 (2.52) 11.24 (3.25) 1.13 .136 0.36
5 – 18 5 – 15
Verbal memoryb 12.13 (2.49) 10.22 (2.43) 1.91 .003* 0.77
5 – 17.5 7 – 15.5
Selective
attentionb
10.07 (2.96) 8.24 (4.56) 1.99 .024* 0.55
4 – 17 1 – 18
Processing
speeda
103.97 (14.20) 92.29 (19.44) 2.75 .003* 0.76
65 – 131 53 – 126
Note. CC = Childhood cancer; SD = standard deviation; n = sample size; t = t-value
p = level of statistical significance, *< .05.
aStandard score (mean 100, SD 15)
bScaled score (mean 10, SD 3)
cg Hedges for continuous variables with unequal sample sizes
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other cognitive functions. CNS involvement and age at diagnosis together
explained 9.9% additional variance than the percentage of the variance
that was explained solely by CNS involvement. This increase in variance
was statistically significant (ΔF(3,73) = 4.05, p = .01). Thus, a total of 18.1% of
the variance in verbal memory was accounted for (F(4,73) = 5.23, p < .001).
Neither radiation treatment nor years since cancer treatment emerged as sig-
nificant predictors in addition to CNS involvement. Note that the clinical risk
factors (e.g., age at diagnosis, years since cancer treatment) are confounded.
Nevertheless, multicollinearity was assessed and was shown not to be an
issue for the present analysis. For details, see supplementary information
(Table S7).
Discussion
Cognitive and psychosocial functioning and health-related quality of life
This study examined the late effects of CC on cognitive performance, psychoso-
cial behaviour, and health-related quality of life. Beyond this, relations between
these domains were investigated. This holistic approach allowed us to adopt a
multi-view perspective on and between different functional domains. Conse-
quently, the results offer comprehensive insights into the long-term effects of
CC in children and adolescents and the results add to the existing research
on cognitive, psychosocial, and quality of life outcomes in adults after childhood
cancer (Ehrhardt et al., 2018).
Figure 2. Percentage of childhood cancer (CC) subgroups with performance below the norma-
tive range in cognitive domains. The dotted line indicates the cut-off of the percentage of sur-
vivors expected to perform below the normative range according to the Gaussian distribution.
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In this study, the cognitive and psychosocial functioning of the CC survivors
was poorer in a number of domains than that of healthy controls. However,
some of these group differences appear to emerge because of above average
performance of the control sample rather than below average performance of
survivors. The mean scores that the survivors obtained on all the measures of
cognitive and psychosocial functioning and quality of life fell within the norma-
tive range. It is important to acknowledge possible sampling bias in this study
whereby survivors with good outcomes may have been overrepresented.
Further, participants living close to the university hospital and those with
good family resources may have been more likely to participate. Additionally,
the good cognitive outcome of our CC survivor group likely represents the
high quality of medical care received during and after the cancer disease.
Thus, the generalizability of the results to the entire survivor population is
limited. Although group means were indicative of good functional outcomes,
some survivors, especially those with CNS involvement, demonstrated
domain-specific difficulties. Depending on the cognitive domain, a maximum
of 35% of the survivors with and without CNS involvement show cognitive per-
formance below the normative range. Based on the cognitive reserve model
(Richards & Deary, 2005; Stern, 2009), we conclude that a majority of the parti-
cipating survivors (i.e., 84–65%) possesses adequate cognitive reserve capacities
to compensate for the adverse effects of cancer and its treatment. Note, that 15–
16% are expected to fall below the normative range.
In this study, peer and conduct problems were more common among the
survivors than among healthy controls (Hocking et al., 2015; Mendoza et al.,
2019). Interestingly, our data confirm previous findings (Ehrhardt et al., 2018;
Hocking et al., 2015; Puhr et al., 2019; Tonning Olsson et al., 2020): executive
functions, processing speed, and fluid intelligence were correlated with peer
problems, and this was associated with poorer health-related quality of life in
CC survivors. This finding underscores the importance of good executive func-
tions and other cognitive functions for age-appropriate social behaviour and
good quality of life (Ehrhardt et al., 2018; Puhr et al., 2019; Tonning Olsson
et al., 2020; Wolfe et al., 2013). Our data extend the previous findings by Ehr-
hardt et al. (2018) on adult CC survivors for the first time in children and adoles-
cents. Everyday social situations place high demands on executive functions.
Specifically, interactions with peers and adaptive social behaviours necessitate
emotion regulation, social decision-making, and the retention andmanipulation
of information in short-term storage. Future research might be directed at inves-
tigating the mediating role of peer problems on cognitive functions.
Despite good intellectual functioning, the CC survivors demonstrated signifi-
cantly poorer performances on the tests of executive functions, verbal memory,
selective attention, and processing speed than the healthy controls, such as pre-
viously stated (Ellenberg et al., 2009; Krull et al., 2018; Peterson et al., 2019). The
largest group effects emerged for working memory, inhibition, and cognitive
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flexibility. This indicates that the effects of CC on cognitive functioning may
largely converge on the domains that necessitate higher-order cognitive pro-
cesses (Krull et al., 2018; Van Der Plas et al., 2018). The cognitive flexibility of sur-
vivors with CNS involvement was poorer than that of their counterparts without
CNS involvement and irrespective of whether completion time or the number of
errors served as the dependent variable, the effect sizes were large. This pattern
of results did not emerge for the other domains of executive functions. Thus,
when cognitive demands increase, subgroup differences become more pro-
nounced. In particular, CC and its treatment appear to affect the cognitive func-
tions that mature slowly and that are only about to be established at time of
diagnosis or during the later developmental stages (Anderson et al., 2011).
Nevertheless, consistent with past findings, the survivors who participated in
this study also demonstrated poorer performances in more elementary cogni-
tive processes such as processing speed and selective attention (Krull et al.,
2018; Van Der Plas et al., 2018). A considerable percentage of the variance in
the domain of executive functions was explained by processing speed. This
finding supports the hierarchical cascade hypothesis, which suggests that
more elementary cognitive functions (e.g., processing speed) influence
higher-order cognitive functions (i.e., executive functions) (Rose et al., 2008).
This finding might have practical relevance to school authorities; specifically,
schools should support children with disadvantages in the best possible
manner. Our data let us hypothesize that granting survivors additional time
to complete their tasks and examinations may attenuate the performance
gap between them and their peers.
Interestingly, the CC survivors and controls did not differ significantly in their
performance on the test of fluid intelligence. The cognitive pattern that
emerged in this study (i.e., normal fluid intelligence but domain-specific weak-
nesses) is not only consistent with past findings (Kahalley et al., 2013; Krull et al.,
2018) but also underscores the importance of thorough domain-specific diag-
nostics (Wegenschimmel et al., 2017). An intelligence quotient cannot ade-
quately portray a profile of the strengths and weaknesses of an individual.
Indeed, such information is of particular relevance to decisions about rehabilita-
tion and educational guidance (Kahalley et al., 2013; Wegenschimmel et al.,
2017). It should be noted, however, that data on intelligence might not be com-
parable among studies because of the different assessment approaches. We
assessed nonverbal intelligence using a single task (matrix reasoning), while
others often assess intelligence based on many cognitive tasks resulting in a
Full Scale IQ score (i.e., including vocabulary, working memory, processing
speed) (Iyer et al., 2015; Kahalley et al., 2013; Krull et al., 2013; Liu et al.,
2015). Interestingly, Wegenschimmel et al. (2017) showed that the Full Scale
IQ scores of pediatric cancer patients was associated with processing speed,
leading to underestimated general cognitive outcome in patients with low pro-
cessing speed. Likewise, our data present a strong influence of processing speed
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on complex cognitive functions, namely executive functions. It is recommended
that this point be kept in mind when comparing results on intelligence in CC
survivors across studies (Iyer et al., 2015; Kahalley et al., 2013; Krull et al.,
2013; Liu et al., 2015).
Although cognitive late effects were observed in specific cognitive domains,
the mean Kidscreen-10 Index scores that the survivors obtained were indicative
of relatively good health-related quality of life. This finding suggests that the
survivors were psychologically resilient and had adopted healthy coping strat-
egies to cope with their challenging experiences (Vetsch et al., 2018; Zebrack
& Zeltzer, 2003). Their outcome scores ranged from very weak (> 2 SD below
the mean) to very strong (> 2 SD above the mean; see for instance, Beauchamp
et al., 2015 for the classification of neuropsychological impairment). This sub-
stantial variance in cognitive outcomes might be attributable to individual
differences in cognitive and cerebral reserve capacities (Kesler et al., 2010;
Stern, 2009), which serve as a buffer against functional impairment (Richards
& Deary, 2005; Stern, 2009). The cognitive reserve model is consistent with
the observation that children are resilient against adverse effects such as
cancer and its treatment (Rutter, 2013). Resilience theory suggests that survivors
can be protected against adverse events by promoting successful adaptation to
their negative sequelae (Beauchamp & Yeates, 2019; Rutter, 2013). Both the cog-
nitive reserve model and resilience theory attribute the good outcomes
observed among clinical populations to brain plasticity, which facilitates the
adaptation of the CNS to changes in the external and internal milieu (e.g., hos-
pitalization, brain tumour, therapies, stress reaction (Anderson et al., 2011;
Dennis et al., 2014; Rutter, 2013)). This mechanism of CNS adaptation was illus-
trated by Kesler et al. (2010), who demonstrated the neural reorganization by
means of changes in the brain volumes of leukemia survivors. Further neuroima-
ging research is needed to enhance our understanding of the relationship
between cognitive reserve and cerebral reserve capacity.
Clinical risk factors
Our findings suggest that CNS involvement is a key risk factor that predicts cog-
nitive outcomes. However, our own research shows that cerebral alterations on
the level of resting-state functional networks are altered even in CC survivors
without CNS involvement (Spitzhüttl et al., 2020). Past studies have found
that age at diagnosis is linked to cognitive functioning (Mulhern & Palmer,
2003; Mulhern et al., 2004; Sands et al., 2001). Accordingly, age at diagnosis
(in addition to CNS involvement) predicted performance on tests of memory
but none of the other cognitive functions in this study. The present cross-sec-
tional findings suggest that brain development is more vulnerable to the
adverse effects of cancer and its treatment during the early stages of life (Ander-
son et al., 2011; Mulhern & Palmer, 2003). However, the development of
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different cognitive functions follow different trajectories. Thus, there may be
specific periods of vulnerability (Anderson et al., 2011), which determine the
effect of age at diagnosis on cognitive functions.
Limitations
Because of the relative rarity of CC, our sample was heterogeneous with regard
to cancer type, treatment protocols (i.e., treatment modality and intensity), age
at diagnosis, and years elapsed since cancer treatment – all these are clinical risk
factors claimed to impact on functional outcome (Brinkman et al., 2016; Krull
et al., 2013; Krull et al., 2018). For instance, classifying participants into sub-
groups based on treatment protocols or brain tumour localization (i.e., supra-
tentorial and infratentorial) will facilitate the disentanglement of the
contributions of clinical risk factors. However, this was not feasible in our
study because the size of the subgroups was small. Further, comparisons of
the two CC subgroups revealed significant differences in demographic and clini-
cal variables (i.e., age at assessment, age at diagnosis, and treatment duration). It
should be noted that exclusion criteria for healthy controls differed from exclu-
sion criteria for cancer survivors. The presence of chronic illnesses, medical pro-
blems, developmental and mental disorders may influence development and
thus might impact on CC survivors’ functional outcomes. Nevertheless, in
cancer survivors, chronic illnesses, medical problems, developmental or
mental disorders are not entirely independent from the cancer and its treat-
ment. Hence, excluding these survivors would be problematic itself and
might possibly reduce the representativeness of the survivor population. More-
over, many analyses were performed in the current study and thus the prob-
ability of false-positive results has to be considered. The literature shows that
p values are under recent criticism and meaningful differences between
groups should be identified by focusing on effect sizes, rather than interpreting
statistical significance on its own (e.g., Amrhein et al. (2019)).
Neuropsychological assessments are administered in controlled environ-
ments and therefore lack ecological validity. For instance, the selective attention
task requires the participant to pay attention for only two minutes; in contrast,
the school environment places greater attentional demands on students. Con-
sequently, we speculate that some of our participants may experience difficul-
ties in their everyday functioning (e.g., based on teacher reports) despite
obtaining good test scores. Indeed, our holistic approach (assessing late
effects on cognitive and psychosocial behaviour, and quality of life) was not
intended to be exhaustive, and it cannot comprehensively capture the entire
range of late effects that CC survivors may experience. Note, that, as indicated
by supplementary analyses, survivors who participated and survivors who
declined participation were comparable in terms of demographic and clinical
variables (S1 to S4).
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Future directions
In future studies aspects of family functioning (i.e., parenting styles, parental
support and parental mental health) may be integrated to investigate its
influence on cognition, psychosocial functioning, and quality of life after CC
cancer (see for instance Hocking et al. (2011)). Further, to unravel different
aspects relating to recovery over time, clinicians should be encouraged to
conduct long-term follow-ups, enabling close monitoring of developmental tra-
jectories after childhood cancer.
Conclusion
On average, the CC survivors demonstrated good outcomes not only in terms of
cognitive performance but also psychosocial functioning and health-related
quality of life. The present findings suggest good cognitive reserve and resilience
of children and adolescents who were diagnosed with and treated for cancer –
which is likely attributable to cerebral neuronal plasticity. However, there was
substantial variability in cognitive and psychosocial outcomes and the survivors
were more likely to perform below the normative range in specific cognitive
domains. Moreover, cognition and psychosocial behaviour are closely linked
and psychosocial outcome related to the survivor’s health-related quality of life.
Taken together, despite the evidence for good intellectual functioning, which
might point towards adequate reserves, in some survivors, domain-specific
difficulties may emerge years after cancer relating to psychosocial development
and quality of life. CC survivors constitute a vulnerable clinical population that
requires holistic monitoring even years after their cancer treatment and recovery
because cognitive and psychosocial difficulties may emerge only with the
passage of time. Therefore, cognitive rehabilitation programmes and educational
support should be provided when it is most needed to possibly enhance and/or
uphold the cognitive reserves and resilience of children and adolescents.
Acknowledgments
This work was supported by the Fondation Gaydoul (Churerstrasse 47, 8808 Pfäffikon SZ), the
Swiss Cancer Research foundation under Grant KFS-3705-08-2015; KFS-4708-02-2019, the
Dietmar Hopp Stiftung GmbH (Walldorf, Germany), the Hans & Annelies Swierstra Stiftung
(Meggen, Switzerland), and the Berner Stiftung für krebskranke Kinder und Jugendliche,
3010 Bern. In addition, we thank the staff of the Swiss Childhood Cancer Registry for their
support, the participating parents, and their children. The funding sources had no role in
the design of the study, and no role during its execution, analyses, interpretation of the
data, or decision to submit results. We are grateful to our postgraduate students and research
assistants for their support in performing assessments.
Disclosure statement
No potential conflict of interest was reported by the author(s).
NEUROPSYCHOLOGICAL REHABILITATION 19
Funding
This work was supported by the Fondation Gaydoul (Churerstrasse 47, 8808 Pfäffikon SZ), the
Swiss Cancer Research foundation [grant number KFS-3705-08-2015; KFS-4708-02-2019], the
Dietmar Hopp Stiftung GmbH (Walldorf, Germany), the Hans & Annelies Swierstra Stiftung
(Meggen, Switzerland), the Berner Stiftung für krebskranke Kinder und Jugendliche, 3010
Bern; and the Krebsstiftung Thun-BernerOberland, 3600 Thun.
Data availability statement
All data of this study are available upon reasonable request after signing a confidentiality
statement and a data sharing agreement.
ORCID
Mirko Schmidt http://orcid.org/0000-0003-4859-6547
Regula Everts http://orcid.org/0000-0001-6556-3419
References
Amrhein, V., Greenland, S., & McShane, B. (2019). Retire statistical significance. Nature, 567,
305–307. https://doi.org/10.1038/d41586-019-00857-9
Anderson, V., Northam, E., & Wrennall, J. (2019). Developmental neuropsychology. A clinical
approach (2nd ed.). Psychology Press. https://doi.org/10.4324/9781315784847
Anderson, V., Spencer-Smith, M., Coleman, L., Anderson, P., Williams, J., Greenham, M.,
Leventer, R. J., & Jacobs, R. (2010). Children’s executive functions: Are they poorer after
very early brain insult. Neuropsychologia, 48(7), 2041–2050. https://doi.org/10.1016/j.
neuropsychologia.2010.03.025
Anderson, V., Spencer-Smith, M., & Wood, A. (2011). Do children really recover better?
Neurobehavioural plasticity after early brain insult. Brain, 134(8), 2197–2221. https://doi.
org/10.1093/brain/awr103
Beauchamp, M. H., Brooks, B. L., Barrowman, N., Aglipay, M., Keightley, M., Anderson, P.,
Yeates, K. O., Osmond, M. H., & Zemek, R. (2015). Empirical derivation and validation of a
clinical case definition for neuropsychological impairment in children and adolescents.
Journal of the International Neuropsychological Society, 21(8), 596–609. https://doi.org/10.
1017/S1355617715000636
Beauchamp, M. H., & Yeates, K. O. (2019). Introduction to JINS special section: Resilience and
wellness after pediatric acquired brain injury. Journal of the International
Neuropsychological Society, 25, https://doi.org/10.1017/S1355617719000365
Benzing, V., Eggenberger, N., Spitzhuettl, J., Siegwart, V., Pastore-Wapp, M., Kiefer, C.,
Slavovap, N. B., Grotzer, M., Heinks Maldonado, T., Schmidt, M., Conzelmann, A., Steinlin,
M., Everts, R., & Leibundgut, K. (2018). The Brainfit study: Efficacy of cognitive training
and exergaming in pediatric cancer survivors – a randomized controlled trial. BMC
cancer, 18(18), https://doi.org/10.7892/boris.109130
Benzing, V. J., Spitzhüttl, J. S., Siegwart, V., Schmid, J., Grotzer, M., Heinks Maldonado, T.,
Roebers, C. M., Steinlin, M., Leibundgut, K., Schmidt, M., & Everts, R. (2020). Effects of cog-
nitive training and exergaming in pediatric cancer survivors–A randomized clinical trial.
Medicine & Science in Sports & Exercise, 52(11), 2293–2302. https://doi.org/10.1249/MSS.
0000000000002386
20 V. SIEGWART ET AL.
Boudreau, B., & Poulin, C. (2008). An examination of the validity of the family Affluence Scale II
(FAS II) in a general adolescent population of Canada. Social Indicators Research, 94(1), 29–
42. https://doi.org/10.1007/s11205-008-9334-4
Brinkman, T. M., Krasin, M. J., Liu, W., Armstrong, G. T., Ojha, R. P., Sadighi, Z. S., Gupta, P.,
Kimberg, C., Srivastava, D., Merchant, T. E., Gajjar, A., Robison, L. L., Hudson, M. M., &
Krull, K. R. (2016). Long-term neurocognitive functioning and social attainment in adult sur-
vivors of pediatric CNS tumors: Results from the St Jude lifetime cohort study. Journal of
Clinical Oncology, 34(12), 1358–1367. https://doi.org/10.1200/JCO.2015.62.2589
Brown, L., Sherbenou, R. J., & Johnsen, S. K. (2010). Test of nonverbal intelligence: TONI-4. Pro-
ed. https://doi.org/10.1177/0734282911400400.
Cheung, Y. T., Sabin, N. D., Reddick, W. E., Bhojwani, D., Liu, W., Brinkman, T. M., Glass, J. O.,
Hwang, S. N., Srivastava, D., Pui, C.-H., Robison, L. L., Hudson, M. M., & Krull, K. R. (2016).
Leukoencephalopathy and long-term neurobehavioural, neurocognitive, and brain
imaging outcomes in survivors of childhood acute lymphoblastic leukaemia treated with
chemotherapy: A longitudinal analysis. The Lancet Haematology, 3(10), e456–e466.
https://doi.org/10.1016/s2352-3026(16)30110-7
Conklin, H. M., Krull, K. R., Reddick, W. E., Pei, D., Cheng, C., & Pui, C. H. (2012). Cognitive out-
comes following contemporary treatment without cranial irradiation for childhood acute
lymphoblastic leukemia. Journal of the National Cancer Institute, 104(18), 1386–1395.
https://doi.org/10.1093/jnci/djs344
Delis, D., Kaplan, E., & Kramer, J. (2001). Delis-Kaplan executive Function system (D-KEFS).
Psychological Corporation.
Dennis, M., Spiegler, B. J., Simic, N., Sinopoli, K. J., Wilkinson, A., Yeates, K. O., Taylor, H. G.,
Bigler, E. D., & Fletcher, J. M. (2014). Functional plasticity in childhood brain disorders:
When, what, how, and whom to assess. Neuropsychology Review, 24(4), 389–408. https://
doi.org/10.1007/s11065-014-9261-x
Ehrhardt, M. J., Mulrooney, D. A., Li, C., Baassiri, M. J., Bjornard, K., Sandlund, J. T., Brinkman, T.
M., Huang, I.-C., Srivastava, D. K., Ness, K. K., Robison, L. L., Hudson, M. M., & Krull, K. R.
(2018). Neurocognitive, psychosocial, and quality-of-life outcomes in adult survivors of
childhood non-Hodgkin lymphoma. Cancer, 124(2), 417–425. https://doi.org/10.1002/
cncr.31019
Ellenberg, L., Qi Liu, M. S., G, G., Y, Y., Packer, R. J., Mertens, A., Donaldson, S. S., Stovall, M.,
Kadan-Lottick, N., Armstrong, G., Robison, L. L., & Zeltzer, L. K. (2009). Neurocognitive
status in long-term survivors of childhood CNS malignancies: A report from the childhood
cancer survivor study. Neuropsychology, 23(6), 705–717. https://doi.org/10.1037/a0016674
Ewing-Cobbs, L., Prasad, M. R., Landry, S. H., Kramer, L., & DeLeon, R. (2004). Executive func-
tions following traumatic brain injury in young children: A preliminary analysis.
Developmental Neuropsychology, 26(1), 487–512. https://doi.org/10.1207/
s15326942dn2601_7
Fidell, L. S., & Tabachnick, B. G.2003 Preparatory data analysis. In J. A. Schinka & W. F. Velicer
(Eds.), Handbook of psychology: Research methods in psychology, (Vol. 2, p. 115–141). John
Wiley & Sons Inc. https://doi.org/10.1002/0471264385.wei0205
Gilmore, J. H., Knickmeyer, R. C., & Gao, W. (2018). Imaging structural and functional brain
development in early childhood. Nature Reviews Neuroscience, 19(3), 123–137. https://
doi.org/10.1038/nrn.2018.1
Goodman, R. (1997). The strengths and difficulties questionnaire: A research note. J. Child
Psychol. Psychiat., 38(5), 581–586. https://doi.org/10.1111/j.1469-7610.1997.tb01545.x
Hocking, M. C., Hobbie, W. L., Deatrick, J. A., Lucas, M. S., Szabo, M. M., Volpe, E. M., & Barakat, L.
P. (2011). Neurocognitive and family functioning and quality of life among young adult
NEUROPSYCHOLOGICAL REHABILITATION 21
survivors of childhood brain tumors. The Clinical Neuropsychologist, 25(6), 942–962. https://
doi.org/10.1080/13854046.2011.580284
Hocking, M. C., McCurdy, M., Turner, E., Kazak, A. E., Noll, R. B., Phillips, P., & Barakat, L. P. (2015).
Social competence in pediatric brain tumor survivors: Application of a model from social
neuroscience and developmental psychology. Pediatric Blood & Cancer, 62(3), 375–384.
https://doi.org/10.1002/pbc.25300
Iyer, N. S., Balsamo, L. M., Bracken, M. B., & Kadan-Lottick, N. S. (2015). Chemotherapy-only
treatment effects on long-term neurocognitive functioning in childhood ALL survivors: A
review and meta-analysis. Blood, 126(3), 346–353. https://doi.org/10.1182/blood-2015-02-
627414
Kahalley, L. S., Conklin, H. M., Tyc, V. L., Hudson, M. M., Wilson, S. J., Wu, S., Xiong, X., Hinds, P. S.
(2013). Slower processing speed after treatment for pediatric brain tumor and acute lym-
phoblastic leukemia. Psycho-oncology, 22(9), 1979–1986. https://doi.org/10.1002/pon.3255
Kesler, S. R., Tanaka, H., & Koovakkattu, D. (2010). Cognitive reserve and brain volumes in pedi-
atric acute lymphoblastic leukemia. Brain Imaging and Behavior, 4(3-4), 256–269. https://
doi.org/10.1007/s11682-010-9104-1
Krull, K. R., Brinkman, T. M., Li, C., Armstrong, G. T., Ness, K. K., Srivastava, D. K., Gurney, J. G.,
Kimberg, C., Krasin, M. J., Pui, C.-H., Robison, L. L., & Hudson, M. M. (2013). Neurocognitive
outcomes decades after treatment for childhood acute lymphoblastic leukemia: A report
from the St Jude lifetime cohort study. Journal of Clinical Oncology, 31(35), 4407–4415.
https://doi.org/10.1200/JCO.2012.48.2315
Krull, K. R., Hardy, K. K., Kahalley, L. S., Schuitema, I., & Kesler, S. L. (2018). Neurocognitive out-
comes and Interventions in long-term survivors of childhood cancer. Journal of Clinical
Oncology, 36, 2181–2189. https://doi.org/10.1200/JCO.2017
Lidzba, K., Everts, R., & Reuner, G. (2019). Neuropsychologie bei Kindern und Jugendlichen.
Hogrefe Verlag GmbH+Company.
Liu, F., Scantlebury, N., Tabori, U., Bouffet, E., Laughlin, S., Strother, D., McConnell, D., Hukin, J.,
Fryer, C., Briere, M.-E., Montour-Proulx, I., Keene, D., Wang, F., & Mabbott, D. J. (2015). White
matter compromise predicts poor intellectual outcome in survivors of pediatric low-grade
glioma. Neuro-oncology, 17(4), 604–613. https://doi.org/10.1093/neuonc/nou306
Melchers, P., & Preuss, U. (2003). K-ABC: Kaufman assessment battery for children, German
version. Hogrefe & Huber.
Mendoza, L. K., Ashford, J. M., Willard, V. W., Clark, K. N., Martin-Elbahesh, K., Hardy, K. K.,
Merchant, T. E., Jeha, S., Wang, F., Zhang, H., & Conklin, H. M. (2019). Social functioning
of childhood cancer survivors after computerized cognitive training: A randomized con-
trolled trial. Children (Basel), 6(10), https://doi.org/10.3390/children6100105
Miyake, A., Friedman, N. P., Emerson, M. J., Witzki, A. H., Howerter, A., & Wager, T. D. (2000). The
unity and diversity of executive functions and their contributions to complex “frontal Lobe”
tasks: A latent variable analysis. Cognitive Psychology, 41(1), 49–100. https://doi.org/10.
1006/cogp.1999.0734
Moyer, K. H., Willard, V. W., Gross, A. M., Netson, K. L., Ashford, J. M., Kahalley, L. S., Wu, S.,
Xiong, X., & Conklin, H. M. (2012). The impact of attention on social functioning in survivors
of pediatric acute lymphoblastic leukemia and brain tumors. Pediatric Blood & Cancer, 59(7),
1290–1295. https://doi.org/10.1002/pbc.24256
Mucci, G. A., & Torno, L. R. (2015). Handbook of long term care of the childhood cancer survivor.
Springer US.
Mulder, H., Pitchford, N. J., & Marlow, N. (2011). Processing speed mediates executive function
difficulties in very preterm children in middle childhood. Journal of the International
Neuropsychological Society, 17(3), 445–454. https://doi.org/10.1017/S1355617711000373
22 V. SIEGWART ET AL.
Mulhern, R. K., & Palmer, S. L. (2003). Neurocognitive late effects in pediatric cancer. Current
Problems in Cancer, 27(4), https://doi.org/10.1016/S0147-0272(03)00026-6
Mulhern, R. K., Phipps, S., & White, H. (2004). Neuropsychological Outcomes.
Peterson, R. K., Tabori, U., Bouffet, E., Laughlin, S., Liu, F., Scantlebury, N., & Mabbott, D. (2019).
Predictors of neuropsychological late effects and white matter correlates in children
treated for a brain tumor without radiation therapy. Pediatric Blood & Cancer, 66(10),
e27924. https://doi.org/10.1002/pbc.27924
Pickering, S., & Gathercole, S. (2001). Working memory test battery for children (WMTB-C). San
Antonio: Psychological Corporation.
Puhr, A., Ruud, E., Anderson, V., Due-Tønnessen, B. J., Skarbø, A.-B., Finset, A., & Andersson, S.
(2019). Social attainment in physically well-functioning long-term survivors of pediatric
brain tumour; the role of executive dysfunction, fatigue, and psychological and emotional
symptoms. Neuropsychological Rehabilitation, 1–25. https://doi.org/10.1080/09602011.
2019.1677480
Ravens-Sieberer, U., Herdman, M., Devine, J., Otto, C., Bullinger, M., Rose, M., & Klasen, F.
(2014). The European KIDSCREEN approach to measure quality of life and well-being in
children: Development, current application, and future advances. Quality of Life
Research, 23(3), 791–803. https://doi.org/10.1007/s11136-013-0428-3
Richards, M., & Deary, I. J. (2005). A life course approach to cognitive reserve: A model for cog-
nitive aging and development? Annals of Neurology, 58(4), 617–622. https://doi.org/10.
1002/ana.20637
Rose, S. A., Feldman, J. F., Jankowski, J. J., & Van Rossem, R. (2008). A cognitive cascade in
Infancy: Pathways from Prematurity to later mental development. Intelligence, 36(4),
367–378. https://doi.org/10.1016/j.intell.2007.07.003
Rutter, M. (2013). Annual research review: Resilience – clinical implications. Journal of Child
Psychology and Psychiatry, and Allied Disciplines, 54(4), 474–487. https://doi.org/10.1111/j.
1469-7610.2012.02615.x
Sands, S. A., Kellie, S. J., Davidow, A. L., Diez, B., Villablanca, J., Weiner, H. L., M. C. Pietanza, C.
Balmaceda, & Finlay, J. L. (2001). Long-term quality of life and neuropsychologic function-
ing for patients with CNS germ-cell tumors: From the first International CNS Germ-cell
tumor study. Neuro-oncology, 3(3), 174–183. https://doi.org/10.1093/neuonc/3.3.174..
Saykin, A. J., Ables, T. A., & McDonald, B. C. (2003). Mechanisms of chemotherapy-Induced
cognitive disorders: Neuropsychological, Pathophysiological, and neuroimaging perspec-
tives. Seminars in Clinical Neuropsychiatry, 8(4), https://doi.org/10.1016/S1084-3612
(03)00055-8
Spitzhüttl, J., Kronbichler, M., Kronbichler, L., Benzing, B., Siegwart, V., Pastore-Wapp, M.,
Kiefer, C., Slavova, V., Grotzer, M., Roebers, C., Steinlin, M., Leibundgut, K., & Everts, R.
(2020). Impact of non-CNS childhood cancer on resting-state connectivity and its associ-
ation with cognition. Brain and Behavior. https://doi.org/10.1002/BRB3.1931
Stern, Y. (2009). Cognitive reserve. Neuropsychologia, 47(10), 2015–2028. https://doi.org/10.
1016/j.neuropsychologia.2009.03.004
Sterne, J. A., White, I. R., Carlin, J. B., Spratt, M., Royston, P., Kenward, M. G., Wood, A. M., &
Carpenter, J. R. (2009). Multiple imputation for missing data in epidemiological and clinical
research: Potential and pitfalls. BMJ, 338, b2393. https://doi.org/10.1136/bmj.b2393
Tonning Olsson, I., Brinkman, T. M., Wang, M., Ehrhardt, M. J., Banerjee, P., Mulrooney, D. A.,
Huang, I., Ness, K. K., Bishop, M. W., Srivastava, D., Robison, L. L., Hudson, M. M., & Krull,
K. R. (2020). Neurocognitive and psychosocial outcomes in adult survivors of childhood
soft-tissue sarcoma: A report from the St. Jude Lifetime Cohort. Cancer, 126(7), 1576–
1584. https://doi.org/10.1002/cncr.32694
NEUROPSYCHOLOGICAL REHABILITATION 23
van der Linden, S. D., Gehring, K., De Baene, W., Emons, W. H. M., Rutten, G. M., & Sitskoorn, M.
M. (2020). Assessment of executive functioning in patients with meningioma and low-
grade glioma: A comparison of self-report, proxy-report, and test performance. Journal
of the International Neuropsychological Society, 26(2), 187–196. https://doi.org/10.1017/
S1355617719001164
Van Der Plas, E., Erdman, L., Nieman, B. J., Weksberg, R., Butcher, D. T., O’Connor, D. L.,
Aufreiter, S., Hitzler, J., Guger, S. L., Schachar, R. J., Ito, S., & Spiegler, B. J. (2018).
Characterizing neurocognitive late effects in childhood leukemia survivors using a combi-
nation of neuropsychological and cognitive neuroscience measures. Child
Neuropsychology, 24(8), 999–1014. https://doi.org/10.1080/09297049.2017.1386170
Vetsch, J., Wakefield, C. E., Robertson, E. G., Trahair, T. N., Mateos, M. K., Grootenhuis, M.,
Marshall, G. M., Cohn, R. J., & Fardell, J. E. (2018). Health-related quality of life of survivors
of childhood acute lymphoblastic leukemia: A systematic review.Quality of Life Research, 27
(6), 1431–1443. https://doi.org/10.1007/s11136-018-1788-5
Wechsler, D. (2003). Wechsler intelligence scale for children-WISC-IV. Pearson.
Wegenschimmel, B., Leiss, U., Veigl, M., Rosenmayr, V., Formann, A., Slavc, I., & Pletschko, T.
(2017). Do we still need IQ-scores? Misleading interpretations of neurocognitive
outcome in pediatric patients with medulloblastoma: A retrospective study. Journal of
Neuro-oncology, 135(2), 361–369. https://doi.org/10.1007/s11060-017-2582-x
Wolfe, K. R., Walsh, K. S., Reynolds, N. C., Mitchell, F., Reddy, A. T., Paltin, I., & Madan-Swain, A.
(2013). Executive functions and social skills in survivors of pediatric brain tumor. Child
Neuropsychology, 19(4), 370–384. https://doi.org/10.1080/09297049.2012.669470
Zebrack, B. J., & Zeltzer, L. K. (2003). Quality of life issues and cancer survivorship. Current
Problems in Cancer, 27(4), https://doi.org/10.1016/S0147-0272(03)00027-8
24 V. SIEGWART ET AL.
